CARDIOL THERAPEUTICS INC-A (CRDL)
CA14161Y2006 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -28.13M | -30.93M | -31.64M | -20.64M | -13.68M | |||
| Depreciation Amortization | 248.35K | 220.00K | 220.00K | 230.00K | 150.00K | |||
| Change In Working Capital | -545.88K | 5.75M | 80.00K | 8.32M | -1.62M | |||
| Other non cash items | 3.25M | -2.26M | 7.79M | 2.91M | 3.77M | |||
| OPERATING CASH FLOW | -25.18M | -27.22M | -23.55M | -9.19M | -11.38M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -64.31K | -70.00K | -10.00K | -40.00K | -420.00K | |||
| INVESTING CASH FLOW | -64.31K | -70.00K | -10.00K | -40.00K | -420.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -55.38K | -50.00K | -50.00K | -50.00K | -20.00K | |||
| Stock Issued/Repurchased | N/A | 0.00 | 98.73M | 17.43M | 2.05M | |||
| Other Financing Activity | N/A | 0.00 | -5.24M | -1.09M | 0.00 | |||
| FINANCING CASH FLOW | -55.38K | -50.00K | 93.44M | 16.30M | 2.03M | |||
| Exchange Rate Effect | 762.04K | 2.92M | N/A | N/A | N/A | |||
| CHANGE IN CASH | -24.54M | -24.42M | 69.88M | 7.07M | -9.77M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -25.18M | -27.22M | -23.55M | -9.19M | -11.38M | |||
| Capital Expenditure | -64.31K | -70.00K | -10.00K | -40.00K | -420.00K | |||
| FREE CASH FLOW | -25.24M | -27.29M | -23.56M | -9.23M | -11.80M | |||
All data in CAD